Interpreta Featured in Group Practice Journal - "Massive Genomic Data Needs Predicted"

Interpreta Featured in Group Practice Journal - "Massive Genomic Data Needs Predicted"

November 3, 2017 - It’s predicted that the computing power required to use genomic data will soon be equal to – or more demanding than – the three other major generators of big data: astronomy, YouTube, and Twitter. With over 49,000 genetic tests for 9,000+ human conditions, the use of genomic data to inform and improve patient care decisions continues to grow. But to be effective, the data needs to be continuously interpreted alongside changes in clinical context and other factors.

Read More

Interpreta Featured in ClinicalOMICs – “Retail Engagement: Interpreta and higi eye healthcare 'roadmaps' using patient data collected at grocers, pharmacies"

October 6, 2017 - The Sept/Oct issue of ClinicalOMICs talks about the Interpreta and higi partnership which, for the first time, integrates biometric data from higi health stations with clinical, claims, and genomic data from Interpreta to enable physicians and insurers to create personalized-care plans for patients. Read the full article on how the partnership is making direct-to-consumer (DTC) healthcare possible and empowering patients

Read the full article here

Interpreta has been recognized as one of the “10 Most Promising Healthcare Analytics Solution Providers” by Healthcare Tech Outlook Magazine

August 11, 2017 - Interpreta is featured as the cover story for the publication’s August issue, with company founders on the cover. Healthcare Tech Outlook recognizes Interpreta as “pioneering the future of clinical interpretation” through its ability to enable precision medicine.

Read the full article here

Interpreta Executives Address How Genomic Medicine Will Enhance Clinical Practice in Becker's Hospital Review

Interpreta Executives Address How Genomic Medicine Will Enhance Clinical Practice in Becker's Hospital Review

April 3, 2017 - What is genomic medicine? And how is it primed to not only improve care, but make it more cost-effective? Interpreta’s Jaime Barea MD, Director of Medical Genetics; Tim Sayed MD, MBA, Vice President, Physician Engagement; and Benjamin Yu, MD PhD, Vice President, Medical Informatics and Genomics at Interpreta recently published an article on this topic in Becker’s Hospital Review.

Read More

Interpreta VP Addresses Precision Medicine Challenges and Opportunities in For the Record Magazine

Interpreta VP Addresses Precision Medicine Challenges and Opportunities in For the Record Magazine

August 19, 2016 - Interpreta's Vice President of Physician Engagement, Tim Sayed, M.D., MBA, writes in For The Record magazine about the implications of precision medicine in practice and the role technology plays in implementing true precision medicine.

Read the article at Precision Medicine: It's Complicated

Read More